Description
Latin name
CALCIUM-D3 NYCOMED
Pharmacological action
Combined drug that regulates the exchange of calcium and phosphorus in the body (in bones, teeth, nails, hair, muscles).
Reduces resorption (resorption) and increases bone density, making up for the lack of calcium and vitamin D3 in the body, necessary for mineralization of the teeth.
Calcium is involved in the regulation of nerve conduction, muscle contractions and is a component of the blood coagulation system. Adequate calcium intake is especially important during growth. during pregnancy and lactation.
Vitamin D3 enhances intestinal calcium absorption.
The use of calcium and vitamin D3 prevents the increase in the production of parathyroid hormone, which is a stimulator of increased bone resorption (leaching of calcium from bones).
Indications
Prevention and treatment of calcium and / or vitamin D3 deficiency
Prevention and treatment of osteoporosis and its complications (bone fractures).
Contraindications
Hypercalcemia
Hypercalciuria
Nephrolithiasis
Hypervitaminosis D
Renal insufficiency of severe degree
Active form of tuberculosis srdloc drug type 3
The drug contains aspartame, which in the body is transformed into phenylalanine, so the drug should not be taken with phenylketonuria.
The drug contains sorbitol, isomalt and sucrose, so its use is not recommended for patients with hereditary fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase deficiency.
Caution: pregnancy, lactation, renal failure.
Use during pregnancy and lactation
Calcium and vitamin D3 are used during pregnancy to make up for their deficiency in the body.
During pregnancy, the daily dose should not exceed 1500 mg of calcium and 600 IU of vitamin D3.
Hypercalcemia due to overdose during pregnancy can have an adverse effect on the developing fetus.
The drug is used during lactation. Calcium and vitamin D3 can pass into breast milk, so you need to consider the intake of calcium and vitamin D from other sources in the mother and baby.
special instructions
With prolonged therapy, serum calcium and creatinine should be monitored.
Surveillance is especially important in elderly patients with concurrent treatment with cardiac glycosides and diuretics and in patients with an increased tendency to form kidney stones. In cases of hypercalcemia or signs of impaired renal function, the dose should be reduced or treatment should be discontinued.
Vitamin D should be taken with caution in patients with renal failure. In this case, it is necessary to control the content of calcium and phosphates in the blood serum. It is also necessary to take into account the risk of soft tissue calcification.
In order to avoid overdose, it is necessary to consider the additional intake of vitamin D from other sources.
Calcium and vitamin D3 should be used with caution in immobilized patients with osteoporosis due to the risk of developing hypercalcemia.
Concomitant use with tetracycline or quinolone antibiotics is usually not recommended, or should be done with caution.
Effect on the ability to drive vehicles and control mechanisms
The drug does not affect the ability to drive vehicles or work with technically complex mechanisms.
Composition
1 tablet contains:
Calcium carbonate 1250 mg (equivalent to elemental calcium 500 mg)
Colecalciferol (vit. D3) 5 ?g (200 IU) as concentrate colecalciferol
Excipients:
Cg – 31.8 mg
Povidone – 36.4 mg
Magnesium stearate – 6.00 mg
Aspartame – 1.00 mg.
Dosage and administration
Tablets can be chewed or dissolved and taken with food. Calcium-D3 Nycomed
Adults for the prevention of osteoporosis – 1 tab. 2 times / day in the treatment of osteoporosis – 1 tab. 2-3 times / day.
To supplement the deficiency of calcium and vitamin D for adults and children over 12 years old – 1 tab. 2 times / day, for children from 5 to 12 years – 1-2 tablets / day, for children from 3 to 5 years – dosage in accordance with the doctor’s recommendations.
Side effects of
The frequency of side effects of the drug is estimated as follows:
very frequent (> 1/10)
frequent (> 1/100, 1/1000, 1/10 000, from the side of metabolism and nutrition)
infrequent – hypercalcemia hypercalciuria.
From the digestive system: rarely – constipation, flatulence, nausea, abdominal pain, diarrhea, dyspepsia.
From the skin and subcutaneous tissue: very rarely – itching, rash, urticaria.
Drug Interactions
Hypercalcemia can potentiate the toxic effects of cardiac glycosides when used together with calcium and vitamin D. It requires monitoring of ECG and serum calcium.
Calcium preparations may decrease the absorption of tetracyclines from the gastrointestinal tract. Therefore, tetracycline drugs should be taken at least 2 hours before or 4-6 hours after taking the drug.
To prevent a decrease in the absorption of bisphosphonate preparations, it is recommended to take them at least 1 hour before taking Calcium-D3Nycomed.
corticosteroids reduce the absorption of calcium, so treatment with corticosteroids may require an increase in the dose of calcium-D3Nikomed.
With the simultaneous use of thiazide diuretics, the risk of hypercalcemia increases, because they increase tubular reabsorption of calcium. With the simultaneous use of thiazide diuretics, the serum calcium content should be regularly monitored.
Calcium reduces the effectiveness of levothyroxine, reducing its absorption. The time period between doses of levothyroxine and Calcium-D3 Nikomed should be at least 4 hours.
Absorption of quinolone antibiotics decreases with simultaneous use with calcium preparations. Therefore, quinolone group antibiotics should be taken 2 hours before or 6 hours after taking Calcium-D3Nycomed.
Taking foods containing oxalates (sorrel, rhubarb, spinach) and phytin (cereals) reduces the absorption of calcium, so you should not take Calcium-D3 Nikomed within 2 hours after eating sorrel, rhubarb, spinach, cereals.
Overdose
Symptoms:
Manifestations of hypercalcemia – anorexia, thirst, polyuria, muscle weakness, nausea, vomiting, constipation, abdominal pain, fatigue, bone pain, mental disorders, nephrocalcinosis, urolithiasis, and in severe and severe cases.
With prolonged use of excess doses (over 2500 mg of calcium) – kidney damage, soft tissue calcification.
If symptoms of an overdose are detected, the patient should discontinue calcium and vitamin D, as well as thiazide diuretics and cardiac glycosides, and consult a physician.
Treatment:
gastric lavage
fluid loss replacement
use of loop diuretics (eg furosemide), GCS, calcitonin, bisphosphonates.
Blood plasma electrolytes, kidney function and diuresis should be monitored. In severe cases, measurement of central venous pressure and ECG monitoring are required.
Storage conditions
The product should be stored in a tightly closed vial, in a dry, out of the reach of children at a temperature not exceeding 25 ° C.
Shelf life
3 years. Do not use after expiration date.
dosage form
lozenges
Indications
Indications
In case of menopause, From menopause, active growth, From bone fractures
Takeda Pharmaceuticals Ltd., Russia
